Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 06/18/2026 | PUT | $380.00 | 1,010 | +635 | +169.33% |
| 04/17/2026 | PUT | $470.00 | 350 | +203 | +138.10% |
| 04/17/2026 | PUT | $410.00 | 254 | +200 | +370.37% |
| 06/18/2026 | CALL | $470.00 | 117 | +69 | +143.75% |
| 02/20/2026 | CALL | $530.00 | 87 | +65 | +295.45% |
| 12/18/2026 | PUT | $440.00 | 72 | +59 | +453.85% |
| 02/20/2026 | PUT | $470.00 | 345 | -27 | -7.26% |
| 06/17/2027 | CALL | $500.00 | 1,739 | -58 | -3.23% |
| 02/13/2026 | PUT | $475.00 | 121 | -128 | -51.41% |
| 02/20/2026 | PUT | $475.00 | 106 | -145 | -57.77% |
| 02/20/2026 | PUT | $465.00 | 27 | -205 | -88.36% |
| 02/13/2026 | PUT | $465.00 | 25 | -217 | -89.67% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.04% | 7.8M | 2.7B |
| Vanguard 500 Index Fund | 2.31% | 5.93M | 2.05B |
| Growth Fund Of America Inc | 1.99% | 5.12M | 1.77B |
| Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 1.31% | 3.38M | 1.17B |
| Fidelity Contrafund Inc | 1.27% | 3.26M | 1.13B |
| Vanguard Specialized-Health Care Fund | 1.24% | 3.18M | 1.1B |
| Fidelity 500 Index Fund | 1.09% | 2.81M | 973.81M |
| SPDR S&P 500 ETF Trust | 1.08% | 2.78M | 963.23M |
| New Perspective Fund Inc | 1.03% | 2.64M | 914.72M |
| American Balanced Fund | 0.89% | 2.3M | 795.94M |
Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica
02/03 02:56 am
GlobeNewswire Inc.
Read moreAutologous Cell Therapy Market Size to Reach US$ 44.55 Billion by 2033 | Astute Analytica
01/27 02:43 pm
GlobeNewswire Inc.
Read moreBreaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets
01/23 01:56 pm
GlobeNewswire Inc.
Read moreStock Market Today, Jan. 15: ImmunityBio Surges After Anktiva Revenue Jumps 700%
01/15 06:27 pm
The Motley Fool
Read morePrediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
01/14 12:15 pm
The Motley Fool
Read morePrediction: 2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026
01/09 10:30 am
The Motley Fool
Read moreEntrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases
01/08 08:00 am
GlobeNewswire Inc.
Read moreMy 10 Top Stocks to Buy to Start the New Year Off Right
01/05 09:15 pm
The Motley Fool
Read moreGene Therapy: 5 Biotech Stocks Chasing the $36B Prize
01/02 02:29 pm
Benzinga
Read more3 Supercharged Growth Stocks to Buy and Hold Into the 2030s
12/28 02:13 pm
The Motley Fool
Read moreIs CRISPR Therapeutics Stock Yesterday's News?
12/24 05:15 am
The Motley Fool
Read more12 Days of Investing: My Top 12 Stocks to Buy Before 2026
12/15 12:10 pm
The Motley Fool
Read more2 Stocks That Could Soar by 52% and 282%, According to Wall Street
12/07 10:25 am
The Motley Fool
Read moreDown 10%, Should You Buy the Dip on Vertex Pharmaceuticals?
12/06 08:15 pm
The Motley Fool
Read more1 Reason I'll Never Sell Vertex Pharmaceuticals Stock
12/04 04:10 pm
The Motley Fool
Read moreSickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM, Owing to the Increasing Prevalence, Awareness, and Advancements in Gene Therapies | DelveInsight
12/03 02:00 pm
GlobeNewswire Inc.
Read more2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
12/03 07:15 am
The Motley Fool
Read moreMeet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50%
11/30 05:10 am
The Motley Fool
Read moreWhere Will Vertex Pharmaceuticals Be in 5 Years
11/27 07:31 am
The Motley Fool
Read more2 Healthcare Stocks For Beginner Investors With a 30-Year Time Horizon
11/23 11:28 am
The Motley Fool
Read more1 Incredible Reason to Buy Vertex Pharmaceuticals Stock in November
11/17 08:15 am
The Motley Fool
Read moreMy 3 Favorite Stocks to Buy Right Now
11/16 10:30 am
The Motley Fool
Read moreNeuer Europachef bei Vertex treibt Produktinnovationen voran und stärkt Lösungen für Compliance
10/30 04:00 am
GlobeNewswire Inc.
Read moreVertex Appoints New Leader in Europe to Advance Product Innovation and Strengthen Compliance
10/30 04:00 am
GlobeNewswire Inc.
Read more2 Unstoppable Growth Stocks to Buy During a Market Crash
10/15 04:33 am
The Motley Fool
Read moreHealthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead
10/08 10:15 am
The Motley Fool
Read moreWorried About Tariffs? 2 Safe Haven Stocks to Buy on the Dip With $500
10/07 03:15 am
The Motley Fool
Read more2 Beaten-Down Stocks Primed for a Comeback
10/05 02:30 pm
The Motley Fool
Read more10 Health Care Stocks With Whale Alerts In Today's Session
09/29 01:35 pm
Benzinga
Read moreThis Chewy Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
09/25 07:26 am
Benzinga
Read moreThalassemia Treatment Market to Witness Significant Growth by 2034 Driven by Novel Drug Development | DelveInsight
09/22 01:00 pm
GlobeNewswire Inc.
Read moreWhy This Biotech Company Could Be a Growth Stock Powerhouse
09/17 05:10 am
The Motley Fool
Read more1 Reason Wall Street Is Obsessed With Vertex Pharmaceuticals
09/15 07:30 am
The Motley Fool
Read moreCRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025
09/09 04:00 pm
GlobeNewswire Inc.
Read moreWhy This Biotech Company Could Be a Growth Stock Powerhouse
09/04 10:15 am
The Motley Fool
Read moreNerve Pain Relief in 2025: What OTC Supplement Alternatives Beyond Prescriptions Are People Exploring?
08/21 05:42 pm
GlobeNewswire Inc.
Read moreWhat's Wrong With Vertex Pharmaceuticals Stock?
08/20 04:14 am
The Motley Fool
Read moreEntrada (TRDA) Q2 Revenue Drops 98%
08/06 07:21 pm
The Motley Fool
Read moreWeakness In Vertex Stock Seen As Buying Opportunity
08/05 02:05 pm
Benzinga
Read moreUp 50% in 3 Months, Is This Stock Still a Buy?
08/05 07:15 am
The Motley Fool
Read more2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right Now
08/01 06:30 am
The Motley Fool
Read moreChronic Pain Associated with Painful Diabetic Neuropathy Market Sees is Predicted to Surge During the Forecast Period (2025–2034) with New Treatment Innovations and Expanding Research Spending | DelveInsight
07/31 01:00 pm
GlobeNewswire Inc.
Read moreThe 3 Things That Matter for Vertex Pharmaceuticals Now
07/28 07:15 am
The Motley Fool
Read more3 Healthcare Stocks to Buy Before They Announce Game-Changing Clinical Trial Results
07/22 04:14 am
The Motley Fool
Read more3 Monster Stocks in the Making to Buy Right Now
07/21 12:07 am
The Motley Fool
Read moreRoyalty Pharma Declares Third Quarter 2025 Dividend
07/18 08:15 am
Benzinga
Read more10 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
07/12 04:20 am
The Motley Fool
Read moreBreaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
07/09 08:30 am
Benzinga
Read more